B Braun OEM Division - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

B Braun OEM Division


B. Braun OEM Division

Customized Kits – from concept to customization.

As one of the leading companies in the healthcare market, B. Braun is your professional and reliable outsourcing partner for pharmaceutical contract manufacturing and customized medical devices. Our product line has everything for safe and exact infusion therapy.

Based on our extensive product portfolio, long lasting experiences and our complete project management capabilities we are your ideal partner to provide you with standard products or products with modified characteristics assembled in customized kits. Based on your drug we can offer you all disposable items which are required for a certain procedure. You can use your possibility to combine different products or to pair one of our products with one of yours. Your possibilities are nearly endless. We also cover registration issues on the basis of your indications (e.g. labeling, instructions for use, documents, registration).

Visit our booth no. 42F29 at the ICSE in Frankfurt and learn more about how we design, combine and produce customized kits for dozens of applications. We accompany you from your first idea to your individual kit.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
20%
Attracting a skilled workforce
28%
Obtaining/maintaining adequate financing
12%
Regulatory compliance
40%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here